WDR5 inhibitors and modulators
US10160763B2 · kind B2 · utility
5Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2017 |
| Grant date | Dec 25, 2018 |
| Priority date | — |
| Expiry date | Sep 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described are compounds that disrupt the WDR5-MLL1 protein-protein interaction, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating disorders and conditions in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.